Table 1 Characteristics of 470 non-diabetic men included in the present study (mean ± SD or proportion).

From: Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance

Trait

 

M/IA

5.3 ± 2.4

Fasting glucose (mmol/L)

5.4 ± 0.6

Fasting insulin (mU/L)

13.6 ± 6.6

OGTT glucose (AUC)

56.0 ± 30.0

OGTT insulin (AUC)

1225.9 ± 749.5

Current smokerB

20.1%

At least moderate physical activity

88.3%

BMI (kg/m2)

26.0 ± 3.3

Waist circumference (cm)

93.2 ± 9.5

Systolic BP (mmHg)

144 ± 19

Diastolic BP (mmHg)

82 ± 10

Antihypertensive medication

30.2%

Serum triglycerides (mmol/L)

1.4 ± 0.7

Total serum cholesterol (mmol/L)

5.9 ± 1.0

HDL-cholesterol (mmol/L)

1.3 ± 0.4

Lipid medicationB

10.2%

C-reactive protein (mg/L)

3.3 ± 4.7

  1. AHEC M/I in mg × kg−1 × kg BW−1 × min−1 per mU/L × 100.
  2. BMissing responses (3.3% for smoking, 1.7% for lipid medication) counted as “no”.